Trial intelligence / Profile preview

Vitamin D for COVID-19 Outpatients

NCT04489628Phase 2Withdrawn

Sponsor
University Hospitals Cleveland Medical Center
Start
Aug 2020
Primary completion
Jun 2021
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of vitamin d in coronavirus disease 2019 (COVID-19), sponsored by University Hospitals Cleveland Medical Center. Planned start Aug 2020; status: withdrawn.

02

Drugs

vitamin d
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04489628.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04489628.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call